Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandra Bhagat PharmaBOM:542934 +4.98%65 OCF Yield % is 35.18 as of Jul. 19, 2026, which is 333% above its 10-year median of 8.13. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.19 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 117 Medical Distribution companies, Chandra Bhagat Pharma ranks better than 91.45% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Chandra Bhagat Pharma OCF Yield % Related Terms
Chandra Bhagat Pharma OCF Yield % Historical Data
* Premium members only.
The historical data trend for Chandra Bhagat Pharma's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542934 vs MCK, CAH, COR: OCF Yield % Comparison
For the Medical Distribution subindustry, Chandra Bhagat Pharma's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma OCF Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Chandra Bhagat Pharma's OCF Yield % distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chandra Bhagat Pharma (BOM:542934) has a OCF Yield % of 35.18 as of Jul. 19, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Chandra Bhagat Pharma and its competitors. This is 333% above median its historical median of 8.13. According to the industry distribution chart, Chandra Bhagat Pharma ranks #10 out of 117 companies in the Medical Distribution industry, placing it in the top 8.5%.
Is Chandra Bhagat Pharma's OCF Yield % too high?
Chandra Bhagat Pharma's current OCF Yield % of 35.18 is 333% above median its 10-year median of 8.13. The Medical Distribution industry median OCF Yield % is 5.55. Chandra Bhagat Pharma's value of 35.18 is 533.9% above this industry median. Based on the distribution chart, Chandra Bhagat Pharma ranks #10 out of 117 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's OCF Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Chandra Bhagat Pharma ranks #10 out of 117 companies for OCF Yield %. This places Chandra Bhagat Pharma in the top 9% of its industry — outperforming the majority of peers. The industry median OCF Yield % is 5.55. Chandra Bhagat Pharma's value of 35.18 is 533.9% above this benchmark. While the company's 10-year median is 8.13 vs. the industry median of 5.55, Chandra Bhagat Pharma has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Distribution company?
The median OCF Yield % among Medical Distribution companies is 5.55, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chandra Bhagat Pharma's current OCF Yield % of 35.18 is 533.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Chandra Bhagat Pharma and its competitors. For the Medical Distribution industry, the median OCF Yield % is 5.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandra Bhagat Pharma's current OCF Yield % is 35.18, which is 333% above median its own 10-year median of 8.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.19, compared to a current price of ₹34.79 — trading 50.4% below its estimated fair value. The current OCF Yield % is 35.18, which is 333% above median its 10-year median of 8.13 and 533.9% above the Medical Distribution industry median of 5.55. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current OCF Yield % is 35.18 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?
Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued.
The current stock price of ₹34.79 is trading 50.4% below its estimated GF Value™ of ₹70.19.
GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.
Key valuation signals for BOM:542934:
OCF Yield %: 35.18 (333% above median its 10-year median of 8.13)
GF Value™: ₹70.19 vs. price of ₹34.79 (50.4% below fair value)
Industry Position: 533.9% above the Medical Distribution median (#10 of 117)
No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score
Get the complete analysis for BOM:542934
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542934 has been successfully added to your 
